An Open-label, Randomized, Single-dose, 2×2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets in Healthy Male Volunteers

Trial Profile

An Open-label, Randomized, Single-dose, 2×2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Amlodipine/fimasartan (Primary) ; Amlodipine; Fimasartan
  • Indications Essential hypertension
  • Focus Pharmacokinetics
  • Sponsors Boryung Pharmaceutical
  • Most Recent Events

    • 14 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top